Ocular Therapeutix Inc. buy BiotechBee
Start price
07.09.22
/
60%
€5.70
Target price
31.12.24
€10.00
Performance (%)
43.52%
End price
14.12.24
€8.18
Summary
This prediction ended on 14.12.24 with a price of €8.18. With a performance of 43.52% the BUY prediction by BiotechBee was a big success. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ocular Therapeutix Inc. | 2.797% | 2.797% | -5.308% | 6.291% |
| iShares Core DAX® | -2.486% | 0.323% | 0.748% | 51.017% |
| iShares Nasdaq 100 | -4.401% | 1.587% | 32.085% | 87.968% |
| iShares Nikkei 225® | -4.295% | 0.970% | 50.000% | 61.272% |
| iShares S&P 500 | -2.199% | 2.005% | 22.599% | 65.117% |
According to BiotechBee what are the pros and cons of Ocular Therapeutix Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
Buy mit Kursziel 10,0
In the thread Trading Ocular Therapeutix Inc.
Buy beendet

